Wikidata

(Q44056207)

English

Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF, sargramostim) administered for 3 years as adjuvant therapy of stages II(T4), III, and IV melanoma.

scientific article published in July 2009

In more languages

Statements

title
Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF, sargramostim) administered for 3 years as adjuvant therapy of stages II(T4), III, and IV melanoma (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19483646
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19483646%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 January 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q44056207&oldid=2106092134"